Olympus Corp - Notice regarding additional investment in Corporate Venture Capital Fund "Olympus Innovation Ventures Fund II"

Delayed Japan Exchange			5-day change	1st Jan Change
2,030.50 ^JPY	-0.68%		-2.24%	-14.28%

Published on 12/14/2025
at 06:32 pm EST

Reuters

06:32pm	Olympus Corp – Notice regarding additional investment in Corporate Venture Capital Fund “Olympus Innovation Ventures Fund II”	RE
Dec. 05	Olympus Corporation Announces Voluntary Corrective Action for the Single-Use Ligating Device	CI
Dec. 05	Olympus, W. L. Gore & Associates, Inc. and Conmed Corporation Announce Transition of Commercial Support for the Gore®? Viabil®? Biliary Endoprosthesis in the United States	CI
Nov. 12	Olympus Corporation Announces Management Appointments	CI
Nov. 10	Olympus Shares Jump Most in Six Years on Job Cuts, Overhaul Plan	MT
Nov. 10	Olympus Corporation – Special Call
Nov. 07	Olympus’ Attributable Profit Declines 40% in Fiscal H1	MT
Nov. 07	Japan’s Olympus to reduce headcount by 2,000 in global overhaul – Bloomberg News	RE
Nov. 07	Olympus Corporation Announces Change of Representative Executive Officer and Executive Officer, Effective April 1, 2026	CI
Nov. 07	Olympus Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2026	CI
Nov. 04	Tranche Update on Olympus Corporation’s Equity Buyback Plan announced on May 13, 2025.	CI
Nov. 04	Olympus Corp – to retire treasury shares worth 2.16% of outstanding stock on November 28	RE
Oct. 30	Olympus Corporation’s Equity Buyback announced on May 13, 2025, has closed with 27,630,600 shares, representing 2.45% for ¥49,999.91 million.	CI
Oct. 29	Japan’s Nikkei crosses 51,000 for first time on tech optimism	RE
Oct. 28	Japan’s Nikkei hits record high as AI optimism lifts investor sentiment	RE
Oct. 01	Tranche Update on Olympus Corporation’s Equity Buyback Plan announced on May 13, 2025.	CI
Sep. 26	Olympus Targets Growth With Faster Innovation, AI and Robotics Push	MT
Sep. 25	High Court Dismisses Appeal in Olympus Shareholder Derivative Lawsuit	MT
Sep. 19	Olympus issues voluntary recall for specific lots of Vizishot 2 Flex (19G) EBUS-TBNA needles	RE
Sep. 19	Olympus Issues Voluntary Recall for Specific Lots of Vizishot 2 Flex Ebus -Tbna Needles	CI
Sep. 10	Olympus Corporation, Q1 2026 Earnings Call, Aug 08, 2025
Sep. 02	Olympus Announces U.S. Launch of Newest Imaging Platform for ENT and Urological Applications	CI
Sep. 02	Whisky maker Suntory’s CEO resigns after possible purchase of illegal supplements	RE
Aug. 11	Jefferies Adjusts Olympus’ Price Target to 1,750 Yen From 1,900 Yen, Keeps at Hold	MT
Aug. 08	Olympus Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2026	CI

Duration

Period

7733: Dynamic Chart

Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.

More about the company

Related Posts